Form 4: Elevance Health Director Hay Lewis III Acquires Stock Units

Director Hay Lewis III acquired 601 deferred stock units in Elevance Health, Inc. on May 14, 2025.

Summary

• On May 14, 2025, Lewis Hay III, a director of Elevance Health, Inc., acquired 601 deferred stock units.
• These units were accrued under the company's Board of Directors Compensation Program.
• The deferred stock units will be payable in Elevance Health common stock upon the earlier of (a) five years from the grant date or (b) the date Hay ceases to be a board member, unless a later date is designated.
• Following the transaction, Hay beneficially owns 11,507 shares of common stock.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing indicating a director's acquisition of stock units, which is generally neutral to slightly positive as it shows alignment with the company's future.

Positives

• The acquisition of deferred stock units aligns the director's interests with the long-term performance of the company.
• The compensation program incentivizes board members to remain with the company.

Future Outlook

The deferred stock units will be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. This filing indicates a director's continued investment in the company.

Stakeholder Impact

• The acquisition of stock units by a director can be viewed positively by shareholders as it aligns management's interests with theirs.

Key Dates

Keywords

Elevance Health, Director, Stock Units, Beneficial Ownership, Deferred Compensation, Form 4, ELV